Company in the scope

Selvita

Your Research Partner

Selvita is a reliable partner for customers from pharmaceutical and biotechnology industry. We help filling out your pipeline with promising compounds originated from the best Polish universities. We also improve progress of pre-clinical research by delivering solutions targeted at speeding up and lowering the cost of introducing innovative compounds to the market.

Company profile

Selvita is a product and solution provider for the pharmaceutical and biotechnology industry. We employ a world –class scientific team of professionals dedicated to medicine, pharma, chemistry, molecular biology, biotechnology, and information technology; and cooperate with leading Polish and international universities and research institutes. We deliver comprehensive solutions to customers from pharmaceutical and biotechnology industry targeted at lowering the cost of introducing innovative compounds to the market.

Our activities

Selvita develops its own innovative drugs, which originate from research at Polish universities and later out-licenses them to the customers from the pharmaceutical industry. Selvita is involved in the research projects up to the pre-clinical stage. Our current projects are in the area of oncology, central nervous system, infections and diagnostics. In future we will also be involved in projects in other therapeutic areas.
Selvita is also the owner of BioCentrum, which provides preclinical ADMET services, biochemistry services with special focus on protein engineering and antibody development. It is also involved in Gencron jv. Gencron is a service offering covering the optimum match of genetically identified patient groups to oncology drugs, which are currently under clinical and pre-clinical development (so called drug targeting) but also drugs which failed to achieve the expected milestones during their development cycle (drug repositioning).

Our offer

We deliver comprehensive solutions to customers from the pharmaceutical and biotechnology industry targeted at lowering the cost of introducing innovative compounds to the market. The areas of our activity include:

• Target-based solutions – advanced protein modelling solutions
• Drug discovery – custom in silico library construction
• Lead generation – optimization of lead compounds
• Contract synthesis and synthesis paths optimization
• Information technology for research projects

Contact

Office Krakow North:
ul. Ostatnia 1c
31-444 Kraków
phone: +48 12 410 73 80
fax: +48 12 410 73 82
Poland

Office Krakow South:
ul. Gronostajowa 3
30-387 Kraków
phone: +48 12 664 62 87
fax: +48 12 664 53 93
Poland

www.selvita.com